The Gastrointestinal Microbial Assay Plus (GI-MAP) with zonulin analyses the composition of microbial DNA from a stool sample using advanced quantitative polymerase chain reaction (qPCR) technology. This test provides information about a broad spectrum of microorganisms, including various bacteria, fungi, viruses, and parasites that may be present in the gastrointestinal tract. It also measures important functional markers relevant to digestive and immune processes, such as calprotectin, secretory IgA, pancreatic elastase, and zonulin, which is linked to intestinal barrier integrity. Together, these factors offer valuable insights into the microbial ecosystem and its potential interactions with gut function and overall wellbeing.

The panel includes a range of microbial targets, covering pathogenic, commensal and opportunistic organisms, helping to characterise the microbial balance in the digestive system. Results are reported quantitatively, allowing comparison over time to observe shifts in microbial patterns that might be associated with dietary, lifestyle or other interventions. The test can support explorations into how changes in gut microbiota and barrier-related markers correspond with digestive comfort or general health interests, complementing information gathered from clinical history and lifestyle factors. Optional add-ons such as StoolOMX (measuring bile acids and short-chain fatty acids) and gluten peptide analysis extend the scope of the assessment.

By combining microbial data with immune and digestive markers including zonulin, the Gastrointestinal Microbial Assay Plus (GI-MAP) helps users better understand their gut environment from a wellness and nutritional perspective. The detailed quantitative output is designed to enable ongoing monitoring of microbial profiles and gut function markers as part of broader lifestyle or health optimisation efforts. This test is suitable for individuals interested in gaining a deeper view of their digestive system and microbial interactions without focusing on clinical diagnoses or disease detection.

Gastrointestinal Microbial Assay Plus (GI-MAP) is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Gastrointestinal Microbial Assay Plus (GI-MAP) is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.